MilliporeSigma, a leading science and technology company, operates across healthcare, life science and performance materials. Around 57,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases, to enabling the intelligence of devices – the company is everywhere. In 2019, MilliporeSigma, generated sales of € 16.2 billion in 66 countries.
Most recently, MilliporeSigma launched the Connected Lab Promise Venture to provide best-in-class Lab Management and Science Enablement Tools for our Life Science customers.
The Connected Lab provides a portfolio of digital capabilities and informatics solutions designed to create efficiencies in the lab, such as the LANEXO® System that rapidly documents laboratory consumables data in real time. The LANEXO® System is a vendor neutral solution which offers complete lab coverage in-terms of inventory, safety and compliance management, through its’s custom-developed LANEXO® RFID labels. These labels can be applied to the entire inventory of consumable reagents in the lab, whether sold by MilliporeSigma or other vendors in the market.
In 2019, MilliporeSigma launched Milli-Q® Connect, a cloud-based service portal for its water purification systems, and acquired BSSN Software, a Frost & Sullivan Innovation Award-winning technology for data management solutions, facilitating laboratory data accessibility. The BSSN platform enables the processing, analysis, archiving, and sharing of laboratory data from multiple sources using industry standards like ANiML and SiLA.